Fosamax (alendronate), manufactured by Merck, is in the group of medicines called bisphosphonates. Fosamax alters the cycle of bone formation and breakdown in the body as it slows bone loss while increasing bone mass, which may prevent bone fractures. Fosamax is usually used in men and women to treat or prevent osteoporosis that is caused by menopause or by taking steroids.
However, Fosamax has been linked to a rare jawbone disorder, esophageal cancer, chronic irregular heartbeat and unusual bone fractures, among other side effects. The most alarming to many patients is the link between Fosamax and a severe bone disease that causes the jawbone to die. Osteonecrosis is a disfiguring and disabling condition that usually begins after dental work or other minor trauma, and causes the bone to be exposed. Soon the area becomes infected and rotted, as the overlying tissue erodes and the blood flow to the jawbone stops. This causes tiny breaks that can lead to the whole jawbone collapsing. Common symptoms usually include pain, soft tissue swelling, and infection, loosening of teeth, drainage, and exposed bone. Moreover, recently Fosamax has been linked to low energy femur fractures in those who have documented use of Fosamax for three or more years.
Patients with side effects such as femur fractures, Dead Jaw Syndrome, esophagus problems and musculoskeletal pain have filed lawsuits against Merck. If you or your loved one has suffered side effects from taking Fosamax, contact an experienced litigation attorney at The Evans Law Firm. You may also call us at 415-441-8669 or e-mail us at email@example.com for a free and confidential consultation.